StockData
USANA Health Sciences Inc logo

USANA Health Sciences Inc (USNA) stock

USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.57+0.03 (+0.22%)

Close on Nov 17, 2026Market cap $250.73MP/E –Yield –

USANA Health Sciences cash

Cash and short-term investments held at the end of each period.

USANA Health Sciences's cash was $168.56M at Jul 4, 2026. For fiscal 2025 it was $158.38M, down 12.9% from the year before. Over ten years it grew 0.8% a year on average. The highest annual figure on record is $330.42M in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2025Jan 3, 2026$158.38M-12.9%
FY2024Dec 28, 2024$181.77M-45.0%
FY2023Dec 30, 2023$330.42M+14.6%
FY2022Dec 31, 2022$288.42M+20.3%
FY2021Jan 1, 2022$239.83M-23.1%
FY2020Jan 2, 2021$311.92M+32.8%
FY2019Dec 28, 2019$234.83M+9.6%
FY2018Dec 29, 2018$214.33M-13.3%
FY2017Dec 30, 2017$247.13M+38.1%
FY2016Dec 31, 2016$178.95M+22.0%
FY2015Jan 2, 2016$146.73M+32.0%
FY2014Jan 3, 2015$111.13M-19.1%
FY2013Dec 28, 2013$137.34M+93.9%
FY2012Dec 29, 2012$70.84M+40.7%
FY2011Dec 31, 2011$50.35M0.0%
FY2010Jan 1, 2011$50.35M+268.7%
FY2009Jan 2, 2010$13.66M+2.8%
FY2008Jan 3, 2009$13.28M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jul 4, 2026$168.56M+11.4%
Q1 FY2026Apr 4, 2026$162.75M-9.4%
Q4 FY2025Jan 3, 2026$158.38M-12.9%
Q3 FY2025Sep 27, 2025$145.35M-60.2%
Q2 FY2025Jun 28, 2025$151.34M-54.5%
Q1 FY2025Mar 29, 2025$179.61M-45.3%
Q4 FY2024Dec 28, 2024$181.77M-45.0%
Q3 FY2024Sep 28, 2024$364.89M+18.8%
Q2 FY2024Jun 29, 2024$332.42M+10.7%
Q1 FY2024Mar 30, 2024$328.34M+11.1%
Q4 FY2023Dec 30, 2023$330.42M+14.6%
Q3 FY2023Sep 30, 2023$307.08M+24.4%
Q2 FY2023Jul 1, 2023$300.18M+30.3%
Q1 FY2023Apr 1, 2023$295.45M+24.3%
Q4 FY2022Dec 31, 2022$288.42M+20.3%
Q3 FY2022Oct 1, 2022$246.88M-0.7%
Q2 FY2022Jul 2, 2022$230.37M-13.2%
Q1 FY2022Apr 2, 2022$237.75M-7.5%
Q4 FY2021Jan 1, 2022$239.83M-23.1%
Q3 FY2021Oct 2, 2021$248.70M-10.7%
Q2 FY2021Jul 3, 2021$265.37M+16.7%
Q1 FY2021Apr 3, 2021$256.96M+32.4%
Q4 FY2020Jan 2, 2021$311.92M+32.8%
Q3 FY2020Sep 26, 2020$278.42M+52.4%
Q2 FY2020Jun 27, 2020$227.37M-1.7%
Q1 FY2020Mar 28, 2020$194.10M-13.7%
Q4 FY2019Dec 28, 2019$234.83M+9.6%
Q3 FY2019Sep 28, 2019$182.75M-23.8%
Q2 FY2019Jun 29, 2019$231.35M-9.7%
Q1 FY2019Mar 30, 2019$225.04M-15.5%
Q4 FY2018Dec 29, 2018$214.33M-13.3%
Q3 FY2018Sep 29, 2018$239.75M+25.0%
Q2 FY2018Jun 30, 2018$256.33M+11.8%
Q1 FY2018Mar 31, 2018$266.20M+51.0%
Q4 FY2017Dec 30, 2017$247.13M+38.1%
Q3 FY2017Sep 30, 2017$191.75M+42.5%
Q2 FY2017Jul 1, 2017$229.37M–
Q1 FY2017Apr 1, 2017$176.32M–
Q4 FY2016Dec 31, 2016$178.95M–
Q3 FY2016Oct 1, 2016$134.54M–

More USANA Health Sciences figures

See a number that looks wrong?